Handelsinvest Investeringsforvaltning reduced its stake in Proto Labs Inc (NYSE:PRLB) by 4.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 66,371 shares of the industrial products company’s stock after selling 3,100 shares during the quarter. Proto Labs comprises 1.5% of Handelsinvest Investeringsforvaltning’s holdings, making the stock its 25th largest position. Handelsinvest Investeringsforvaltning’s holdings in Proto Labs were worth $6,837,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Proto Labs by 2.7% during the second quarter. Vanguard Group Inc. now owns 2,176,051 shares of the industrial products company’s stock worth $146,339,000 after purchasing an additional 56,724 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Proto Labs by 411.4% during the second quarter. Janus Henderson Group PLC now owns 1,301,429 shares of the industrial products company’s stock worth $87,521,000 after purchasing an additional 1,046,960 shares during the period. New York State Common Retirement Fund increased its holdings in shares of Proto Labs by 2.1% during the third quarter. New York State Common Retirement Fund now owns 651,475 shares of the industrial products company’s stock worth $52,313,000 after purchasing an additional 13,206 shares during the period. State Street Corp increased its holdings in shares of Proto Labs by 5.2% during the second quarter. State Street Corp now owns 595,748 shares of the industrial products company’s stock worth $40,063,000 after purchasing an additional 29,561 shares during the period. Finally, Conestoga Capital Advisors LLC increased its holdings in shares of Proto Labs by 16.1% during the fourth quarter. Conestoga Capital Advisors LLC now owns 588,419 shares of the industrial products company’s stock worth $60,607,000 after purchasing an additional 81,745 shares during the period.

In related news, Director Rainer Gawlick sold 1,500 shares of Proto Labs stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $90.31, for a total value of $135,465.00. Following the transaction, the director now directly owns 6,925 shares of the company’s stock, valued at $625,396.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Robert Bodor sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $94.79, for a total transaction of $379,160.00. Following the completion of the sale, the vice president now owns 20,578 shares in the company, valued at approximately $1,950,588.62. The disclosure for this sale can be found here. Insiders sold 19,556 shares of company stock worth $1,814,101 over the last three months. 7.78% of the stock is currently owned by insiders.

Shares of Proto Labs Inc (NYSE PRLB) traded down $1.10 during trading hours on Tuesday, reaching $109.10. 12,664 shares of the company were exchanged, compared to its average volume of 118,219. The company has a market capitalization of $2,965.68, a PE ratio of 62.97, a price-to-earnings-growth ratio of 2.42 and a beta of 1.07. Proto Labs Inc has a fifty-two week low of $48.00 and a fifty-two week high of $113.05.

PRLB has been the topic of several recent research reports. BidaskClub cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Friday, October 6th. Zacks Investment Research raised shares of Proto Labs from a “hold” rating to a “buy” rating and set a $96.00 price objective on the stock in a research note on Friday, November 3rd. Craig Hallum set a $92.00 price objective on shares of Proto Labs and gave the company a “hold” rating in a research note on Monday, November 27th. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $84.00 price objective on shares of Proto Labs in a research note on Thursday, December 14th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $86.50.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/proto-labs-inc-prlb-shares-sold-by-handelsinvest-investeringsforvaltning/1832714.html.

Proto Labs Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs Inc (NYSE:PRLB).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.